Publications

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group. by Jones RN, Sader HS and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1994; 20 (2): 93-98

Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results. by Jones RN, Sutton LD, Cantrell HF and Lankford RB published in Diagn. Microbiol. Infect. Dis. 1994; 20 (3): 143-149

Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. by Houston AK and Jones RN published in Diagn. Microbiol. Infect. Dis. 1994; 18 (1): 57-59

Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef. by Biedenbach DJ and Jones RN published in J. Clin. Microbiol. 1994; 32 (2): 559-562

Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: A multicenter molecular epidemiology study. by Sader HS, Pignatari AC, Hollis RJ, Leme I and Jones RN. published in Infect. Control. Hosp. Epidemiol. 1993; 14 (5): 260-264

Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. by Sader HS, Pignatari AC, Leme IL, Burattini MN, Tancresi R, Hollis RJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 1993; 17 (1): 13-18

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5,556 recent clinical isolates from five medical centers. by Sader HS, Jones RN, Washington JA, Murray PR, Gerlach EH, Allen SD and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1993; 17 (2): 143-150

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials. by Jones RN, Erwin ME, Hager HL and Hohl PE published in Diagn. Microbiol. Infect. Dis. 1993; 17 (3): 225-232

Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result. by Jones RN and Zurenko GE published in Diagn. Microbiol. Infect. Dis. 1993; 17 (4): 313-316

Fluoroquinolone (lomefloxacin) international surveillance trial: A report of 30 months of monitoring in vitro activity. by Jones RN published in Am. J. Med. 1992; 92 (4A): 52S-57S

Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a multicenter, national comparative activity surveillance study. The Ofloxacin Surveillance Group. by Jones RN, Reller LB, Rosati LA, Erwin ME and Sanchez ML published in Diagn. Microbiol. Infect. Dis. 1992; 15 (5): 425-434

Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin. by Jones RN and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1992; 15 (8): 693-701

In vitro activity of 43 antimicrobial agents tested against ampicillin- resistant enterococci and Gram-positive species resistant to vancomycin. by Yamane N and Jones RN published in Diagn. Microbiol. Infect. Dis. 1991; 14 (4): 337-345

Antimicrobial susceptibility testing trends and accuracy in the United States. A review of the College of American Pathologists Microbiology Surveys, 1972-1989. Microbiology Resource Committee of the College of American Pathologists. by Jones RN and Edson DC published in Arch. Pathol. Lab. Med. 1991; 115 (5): 429-436

Interpretive criteria, quality control guidelines and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae. by Jones RN, Fuchs PC, Washington JA, Gavan TL, Murray PR, Gerlach EH and Thornsberry C published in Diagn. Microbiol. Infect. Dis. 1990; 13 (6): 499-507

A review of cephalosporin metabolism: A lesson to be learned for future chemotherapy. by Jones RN published in Diagn. Microbiol. Infect. Dis. 1989; 12 (1): 25-31

Multicenter in vitro evaluation of SM-7338, a new carbapenem. by Jones RN, Aldridge KE, Allen SD, Barry AL, Fuchs PC, Gerlach EH and Pfaller MA published in Antimicrob. Agents Chemother. 1989; 33 (4): 562-565

Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococci. by Jones RN and Gardiner RV published in Diagn. Microbiol. Infect. Dis. 1989; 12 (3): 271-273

The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers. by Jones RN, Barry AL, Gardiner RV and Packer RR published in Diagn. Microbiol. Infect. Dis. 1989; 12 (5): 385-394

Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity. by Jones RN published in Antimicrob. Agents Chemother. 1989; 33 (9): 1652-1653

In vitro studies of meropenem. by Jones RN, Barry AL and Thornsberry C published in J. Antimicrob. Chemother. 1989; 24 (Suppl A): 9-29

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5,889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. by Jones RN, Pfaller MA, Fuchs PC, Aldridge K, Allen SD, and Gerlach EH published in Diagn. Microbiol. Infect. Dis. 1989; 12 (6): 489-494

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: Interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. by Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, and Washington JA published in J. Clin. Microbiol. 1989; 27 (12): 2758-2766

Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group. by Barry AL, Fuchs PC and Jones RN published in Diagn. Microbiol. Infect. Dis. 1989; 12 (5): 413-420

Cefotaxime single-dose surgical prophylaxis in a prepaid group practice. Comparisons with other cephalosporins and ticarcillin/clavulanic acid. by Jones RN, Slepack JM and Wojeski WV published in Drugs 1988; 35 (Suppl 2): 116-123

The identification and antimicrobial susceptibility testing of Neisseria gonorrhoeae, 1980-1987. Results from the College of American Pathologists Microbiology Surveys Program. by Jones RN and Edson DC published in Arch. Pathol. Lab. Med. 1988; 112 (5): 485-488

Cefotetan: A review of the microbiologic properties and antimicrobial spectrum. by Jones RN published in Am. J. Surg. 1988; 155 (5A): 16-23

Antibiotic prophylaxis of 1,036 patients undergoing elective surgical procedures. A prospective, randomized comparative trial of cefazolin, cefoxitin, and cefotaxime in a prepaid medical practice. by Jones RN, Wojeski W, Bakke J, Porter C and Searles M published in Am. J. Surg. 1987; 153 (4): 341-346

Single-dose surgical prophylaxis using ticarcillin/clavulanic acid (Timentin): A prospective, randomized comparison with cefotaxime. by Jones RN and Wojeski WV published in Diagn. Microbiol. Infect. Dis. 1987; 7 (3): 219-223

Review of the in vitro spectrum of activity of imipenem. by Jones RN published in Am. J. Med. 1985; 78 (6A): 22-32

Antibiotic susceptibility testing accuracy. Review of the College of American Pathologists Microbiology Survey, 1972-1983. by Jones RN and Edson DC published in Arch. Pathol. Lab. Med. 1985; 109 (7): 595-601

Collaborative evaluation of the microbial profile system for quantitative antimicrobial susceptibility testing. by Gerlach EH, Jones RN and Barry AL. published in J. Clin. Microbiol. 1983; 17 (3): 436-444

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: A collaborative study. by Gavan TL, Jones RN, Barry AL, Fuchs PC, Gerlach EH, Matsen JM, Reller LB, Thornsberry C and Thrupp LD published in J. Clin. Microbiol. 1981; 14 (1): 67-72

Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: A collaborative study. by Gavan TL, Jones RN and Barry AL published in Antimicrob. Agents Chemother. 1980; 17 (3): 464-469

Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: A collaborative study. by Barry AL, Jones RN, and Gavan TL published in Antimicrob. Agents Chemother. 1978; 13 (1): 61-69